Target intelligence / Profile preview

Bothrops phospholipase A2 (PLA2)

Target
PLA2
Molecular classification
Enzyme, Hydrolase, Secretory phospholipase A2, Group IIA phospholipase A2
01

Overview

Bothrops phospholipases A2 (PLA2s) are a diverse group of enzymes found in the venom of pit vipers belonging to the Bothrops genus, which are responsible for the majority of snakebite accidents in Latin America (Gutiérrez & Lomonte, 2013). These enzymes primarily function by hydrolyzing the sn-2 ester bond of glycerophospholipids, leading to the release of fatty acids and lysophospholipids that disrupt cell membranes and trigger inflammatory cascades (Lomonte et al., 2009). In the context of envenomation, Bothrops PLA2s induce severe local effects such as myonecrosis, edema, and hemorrhage, as well as systemic effects like anticoagulation and neurotoxicity (Fernandes et al., 2014). While traditional treatment relies on equine-derived antivenoms, these often fail to neutralize the local tissue damage effectively due to the rapid action of PLA2s (Gutiérrez et al., 1998). Consequently, these enzymes have become critical targets for small-molecule inhibitors like Varespladib, which aim to provide early intervention and reduce the morbidity associated with snakebites (Lewin et al., 2016). Understanding the structural diversity of these enzymes, including both catalytically active (Asp49) and inactive but toxic (Lys49) variants, is essential for developing broad-spectrum therapeutics (UniProt, 2024).

Other names
Snake venom phospholipase A2svPLA2Bothropic PLA2MyotoxinPhosphatidylcholine 2-acylhydrolaseGroup IIA secretory phospholipase A2
02

Mechanism of action

Inhibitors like Varespladib act as competitive antagonists that bind to the active site of the PLA2 enzyme, specifically interacting with the catalytic residues (e.g., His48, Asp49) and the calcium-binding loop, thereby preventing the binding and hydrolysis of phospholipid substrates and the subsequent release of inflammatory mediators (Lewin et al., 2016; PubChem, 2024).

03

Biological functions

Phospholipid hydrolysisMyotoxicityNeurotoxicityAnticoagulationPro-inflammatory activityEdema inductionCell membrane disruption
04

Disease associations

Snakebite envenomationTissue necrosisSystemic inflammationHemorrhageAcute kidney injury
05

Safety considerations

Rapid onset of irreversible tissue damageAntivenom-induced anaphylaxisGeographic and inter-species variability in venom compositionPotential off-target inhibition of human secretory PLA2s
06

Interacting drugs

Varespladib

5 more in the full profile.

07

Biomarkers

Creatine kinaseLactate dehydrogenasePlasma PLA2 activity levelMyoglobinuria

Beyond the preview

Go deeper on Bothrops phospholipase A2 (PLA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bothrops phospholipase A2 (PLA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call